Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag derived from human influenza virus hemagglutinin, providing a consistent platform for protein detection and purification in molecular biology (Wei et al., 2021). This peptide exhibits high solubility in DMSO, ethanol, and water, supporting flexible integration into diverse buffer systems (APExBIO, product page). Its mechanism is based on competitive binding to Anti-HA antibodies, enabling efficient elution of HA-tagged fusion proteins during immunoprecipitation. With >98% purity confirmed by HPLC and MS, it is validated for sensitive protein-protein interaction studies. The product's storage and handling guidelines ensure maximal stability and performance in research workflows.

Biological Rationale

The HA tag peptide was engineered from the epitope region of the influenza A virus hemagglutinin protein. Epitope tags such as HA facilitate the study of protein localization, expression, and interactions by providing a universal antibody target (Wei et al., 2021). In eukaryotic cells, endogenous proteins often lack unique immunogenic epitopes, making exogenous tags essential for selective detection. The HA peptide (YPYDVPDYA) is recognized by well-characterized Anti-HA antibodies, supporting reproducible immunoprecipitation and immunodetection. Its use is especially prevalent in protein-protein interaction studies, exosome pathway analyses, and systems biology workflows. For a deeper context on the translational impact, see Redefining Translational Protein Science, which provides a strategic framework for deploying HA tags in mechanistic studies—this article extends that by offering practical integration parameters and quantitative benchmarks.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide acts as a competitive ligand for Anti-HA antibodies. When added to a protein complex bound to Anti-HA beads or coated plates, the free HA peptide competes with HA-tagged fusion proteins for antibody binding sites. This results in the displacement (elution) of the HA-tagged protein from the antibody matrix. The process is highly specific due to the strong affinity between the YPYDVPDYA sequence and the antibody paratope (Wei et al., 2021). The peptide's small size (~1 kDa) minimizes steric hindrance and does not affect the folding or function of the fusion partner. High solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) allows use in a wide range of elution conditions, including native and denaturing buffers (APExBIO, A6004 kit).

Evidence & Benchmarks

• HA tag peptides enable robust immunoprecipitation and protein detection across cell types and lysate conditions (Wei et al., 2021, DOI).
• Competitive elution with synthetic HA peptide preserves native protein conformation and activity compared to harsh chemical elution (Precision Tag for Protein Purification).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water (APExBIO, product page).
• Purity & identity confirmed by HPLC and mass spectrometry, with >98% purity in the APExBIO A6004 product batch (APExBIO, SKU A6004).
• Validated for use in ESCRT-independent exosome pathway studies, allowing precise isolation of tagged proteins involved in endosomal trafficking (Wei et al., 2021, DOI).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide has broad utility in:

• Immunoprecipitation of HA-tagged fusion proteins
• Competitive elution in protein purification workflows
• Protein-protein interaction mapping
• Exosome biogenesis and trafficking studies
• High-sensitivity detection in Western blot, ELISA, and immunofluorescence assays

For example, Enhancing Protein Interaction Studies provides a Q&A-driven guide to practical challenges in using the APExBIO A6004 peptide; this dossier contributes additional quantitative benchmarks and mechanistic clarity.

Common Pitfalls or Misconceptions

• The HA tag peptide is not suitable for direct detection in the absence of Anti-HA antibodies.
• Long-term storage of peptide solutions (even at -20°C) is not recommended due to potential degradation; store as dry powder.
• The peptide does not facilitate protein purification if the target is not HA-tagged at the genetic or post-translational level.
• Over-saturating the antibody matrix with excess peptide can result in incomplete elution or high background.
• The HA tag does not confer solubility or folding advantages to the fusion partner; it functions only as an epitope tag.

For a broader discussion on limitations and advanced applications, see Precision Epitope Tagging, which this article updates with new evidence from exosome pathway research.

Workflow Integration & Parameters

For optimal performance, dissolve the Influenza Hemagglutinin (HA) Peptide in DMSO, ethanol, or water at the required working concentration. Use freshly prepared solutions for each experiment. Store desiccated at -20°C and avoid repeated freeze-thaw cycles. Typical applications use concentrations ranging from 0.5 to 2 mg/mL for elution, with actual requirements determined empirically. The peptide is compatible with both magnetic bead and plate-based immunoprecipitation formats. In protein-protein interaction studies, HA tagging allows precise mapping of interaction networks and post-translational modifications (Wei et al., 2021). For further integration strategies, Precision Tag for Advanced Applications focuses on how robust competitive binding supports high-throughput workflows, while this dossier provides solubility and purity parameters for critical assay design.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide, as exemplified by the APExBIO A6004 product, is a validated, high-purity tag peptide essential for advanced protein detection and purification. Its robust biochemical properties, paired with standardized antibody reagents, enable high-confidence analysis of protein complexes and pathways, including ESCRT-independent exosome biogenesis (Wei et al., 2021). Ongoing innovation in tag design and antibody engineering will further expand the toolkit for molecular biology and translational research. For ordering information and batch-specific documentation, visit the APExBIO Influenza Hemagglutinin (HA) Peptide product page.